Biopharmaceutical manufacturing refers to the process of producing biological drugs, such as monoclonal antibodies, vaccines, and proteins, used to treat various diseases. This type of drug production is different from traditional pharmaceutical manufacturing, which involves chemical synthesis to produce small molecule drugs. Instead, biopharmaceuticals are produced using living cells, such as bacteria or yeast, which are engineered to produce the desired protein. The biopharmaceutical manufacturing process can be divided into several stages: upstream processing, downstream processing, and formulation. Upstream processing involves the cultivation of cells in bioreactors, while downstream processing involves purifying the biological product from the cell culture and preparing it for formulation. Formulation involves the final preparation of the product for administration, such as mixing it with excipients to form a stable drug product. In conclusion, biopharmaceutical manufacturing is a complex and highly regulated field that plays a crucial role in the production of life-saving drugs. With the increasing demand for biologics and advances in biotechnology, the biopharmaceutical industry is poised for significant growth in the coming years.
